LLLefteris Lykouras

Lefteris Lykouras

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lefteris Lykouras has a total of 87 co-authors. Here are the top co-authors by number of shared publications:

  • Ioannis Michopoulos

    Second Department of Psychiatry University of Athens Athens Greece

    8 shared publications
  • Panagiotis Oulis

    First Department of Psychiatry, University of Athens, Eginition Hospital, Athens, Greece

    5 shared publications
  • Athanasios Douzenis

    2nd Department of Psychiatry, University of Athens, Medical School, Attikon University General Hospital, Athens, Greece

    4 shared publications
  • Christos Christodoulou

    2nd Department of Psychiatry, University of Athens, Medical School, “Attikon” University General Hospital, Athens, Greece

    4 shared publications
  • Rossetos Gournellis

    2nd Department of Psychiatry, University of Athens, Medical School, “Attikon” University General Hospital, Athens, Greece

    4 shared publications
  • Athanasios Douzenis

    Second Department of Psychiatry, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, 1 Rimini St., 12462 Athens, Greece

    3 shared publications

Latest Publications

  • A magnetic resonance imaging study of hippocampal, amygdala and subgenual prefrontal cortex volumes in major depression subtypes: Melancholic versus psychotic depression

    by Konstantina Vassilopoulou, Matilda Papathanasiou, Ioannis Michopoulos, Fotini Boufidou, Panagiotis Oulis, Nikolaos Kelekis, Emmanouil Rizos, Chrysoula Nikolaou, Christos Pantelis, Dennis Velakoulis, et al.


  • Open Access

    A case-control validation of Type D personality in Greek patients with stable coronary heart disease

    by Christos Christodoulou, Athanasios Douzenis, Paula MC Mommersteeg, Loukianos Rallidis, Antonis Poulios, Vasiliki Efstathiou, Georgios Bouras, Christos Varounis, Panagiota Korkoliakou, John Palios, et al.

    Type D personality has been associated with a variety of emotional and social difficulties as well as with poor prognosis in patients with established coronary heart disease (CHD). We examined the psychometric properties and validity of the Type D Scale-14 (DS14) and the prevalence of Type D personality among Greek patients with CHD while taking into account demographic; clinical, such as diabetes mellitus, hypertension, and hypercholesterolemia; as well as psychological variables such as depression, anxiety, and psychological stress.


  • Open Access

    Differences between elderly voluntary and involuntary admitted psychiatric patients in Greece

    by Athanasios Douzenis, Ioannis Michopoulos, Rossetos Gournellis, Christos Christodoulou, Emmanouel N. Rizos, Dionysios Sakkas, Athanasios Karkanias, Ioannis Rontos, Georgios Bouras, Lefteris Lykouras


  • Clinical correlates of age of onset in psychotic depression

    by Rossetos Gournellis, Panagiotis Oulis, Emmanuel Rizos, Evgenia Chourdaki, Agis Gouzaris, Lefteris Lykouras


  • Open Access

    Mitochondrial DNA and anti-mitochondrial antibodies in serum of autistic children

    by Bodi Zhang, Asimenia Angelidou, Konstantinos-Dionysios Alysandratos, Magdalini Vasiadi, Konstantinos Francis, Shahrzad Asadi, Athanasios Theoharides, Kyriaki Sideri, Lefteris Lykouras, Dimitrios Kalogeromitros, et al.

    Autism spectrum disorders (ASD) are neurodevelopmental disorders characterized by difficulties in communication, cognitive and learning deficits, as well as stereotypic behaviors. For the majority of cases there are no reliable biomarkers or distinct pathogenesis. However, increasing evidence indicates ASD may be associated with some immune dysregulation, and may have a neuroimmune component. We recently showed that the peptide neurotensin (NT) is increased in autistic children. We now show that NT induces release of extracellular mitochondrial DNA (mtDNA) that could act as "autoimmune" trigger. We further show that serum from young autistic patients contains mtDNA (n = 20; cytochrome B, p = 0.0002 and 7S, p = 0.006), and anti-mitochondrial antibody Type 2 (n = 14; p = 0.001) as compared to normally developing, unrelated controls (n = 12). Extracellular blood mtDNA and other components may characterize an autistic endophenotype and may contribute to its pathogenesis by activating autoimmune responses.


  • Open Access

    Neurotensin is increased in serum of young children with autistic disorder

    by Asimenia Angelidou, Konstantinos Francis, Magdalini Vasiadi, Konstantinos-Dionysios Alysandratos, Bodi Zhang, Athanasios Theoharides, Lefteris Lykouras, Kyriaki Sideri, Dimitrios Kalogeromitros, Theoharis C Theoharides

    Autism spectrum disorders (ASD) are a group of pervasive neurodevelopmental disorders diagnosed in early childhood. They are associated with a set of "core symptoms" that include disabilities in social interaction skills, verbal and non-verbal communication, as well as repetitive and stereotypic behaviors. There is no definite pathogenetic mechanism or diagnostic tests. Many children with ASD also have "allergic-like" symptoms, but test negative implying mast cell activation by non-allergic triggers. We measured by Milliplex arrays serum levels of 3 neuropeptides that could stimulate mast cells in children with autistic disorder (n = 19; 16 males and 3 females; mean age 3.0 ± 0.4 years) and healthy, unrelated controls (n = 16; 13 males and 3 females; mean age 3 ± 1.2 years). Only neurotensin (NT) was significantly increased from 60.5 ± 6.0 pg/ml in controls to 105.6 ± 12.4 pg/ml in autistic disorder (p = 0.004). There was no statistically significant difference in the serum levels of β-endorphin or substance P (SP). NT could stimulate immune cells, especially mast cells, and/or have direct effects on brain inflammation and ASD.


  • Major depression in elderly medical inpatients in Greece, prevalence and identification

    by Ioannis Michopoulos, Athanasios Douzenis, Rossetos Gournellis, Christos Christodoulou, Christina Kalkavoura, Panagiota G. Michalopoulou, Katerina Fineti, Theodore Liakakos, Kyriaki Kanellakopoulou, Lefteris Lykouras

    Background: The aim of this study was to report the prevalence of episodes of DSM-IV major depression, as well as their identification rates, in elderly inpatients in a general hospital in Greece. Methods: 200 selected patients, 65 years old and over, hospitalized in Surgery and Internal Medicine Departments, were assessed for major depression over a period of 12 months (October 2006–November 2007) by means of SCID-I/P, HADS, BDI and GDS-15. During the same period, liaison calls from the same departments were evaluated and findings were compared. Results: When psychiatric screening was performed, 28 patients (14%) were diagnosed as suffering from a major depressive episode. During the same period, there were only 20 liaison calls from the same departments for patients over 65 years old, from which 4 patients were found to be suffering from major depression. Comparison between the two periods showed significant underestimation of depression. All psychometric scales detected depression sufficiently. Conclusions: In general hospital elderly inpatients, depression still remains underestimated. Depression symptom scales could be used as routine tests for screening major depression.


  • Open Access

    Porencephaly and psychosis: a case report and review of the literature

    by Athanassios Douzenis, Emmanouil N Rizos, Athanasia Papadopoulou, Matilda Papathanasiou, Lefteris Lykouras

    Malformations of the cerebral cortex are often associated with developmental delay and psychoses. Porencephaly is a rare congenital disorder of central nervous system involving a cyst or a cavity filled with cerebrospinal fluid, in brain's parenchyma. We present a 25 years old woman with her first psychotic episode. She also suffers from porencephaly in the frontotemporal lobes region. It is emphasized that the two consistently abnormal brain regions in schizophrenia research had significant damage in this patient since birth. There is a total of only five cases of schizencephaly or porencephaly associated with psychosis in the scientific literature. Their clinical characteristics as well as the imaging results are described. It is unclear if porencephaly and psychosis concur by chance or are causally related. The area where the porencephalic cysts appear seems to be of relevance. This case highlights the need for further research.


  • Tardive dyskinesia in a patient treated with quetiapine

    by Emmanouil Rizos, Athanassios Douzenis, Rossetos Gournellis, Christos Christodoulou, Lefteris P. Lykouras

    Quetiapine is an atypical antipsychotic that is believed to have a low D2 binding affinity in striatal and extrastriatal regions. We report the case of a female patient with the diagnosis of schizoaffective disorder (using DSM-IV-TR criteria) who initially received amisulpride for 3 months, discontinued gradually because of persistent and distressing extra-pyramidal symptoms, and who developed tardive dyskinesia 3 months later after the initiation of quetiapine. A trial with ziprasidone resulted in a further worsening of tardive dyskinesia symptoms. A further trial with aripiprazole, improved her tardive dyskinesia symptoms. Although, it is under consideration the possibility that the improvement could have been due to the discontinuation of quetiapine, we conclude that aripiprazole improved the TD symptoms.


  • Dimensional approach to delusions in psychotic depression in the elderly: factor structure and clinical correlates

    by Rossetos Gournellis, Panagiotis Oulis, Panagiota Michalopoulou, Adamantia Kaparoudaki, Christos Dimitrakopoulos, Lefteris Lykouras

    Objective The present study attempted to investigate the clinically important broader dimensions of clinical characteristics of delusions, through multivariate analysis, in a pure sample of elderly unipolar delusional depressives as well as to test their external validity against a set of demographic, anamnestic and psychopathological validators. Methods Fifty inpatients suffering from psychotic major depression (PMD) in the context of major depressive disorder, 60 years old or older, were assessed on the basis of SCID IV, HRSD, MMSE and by three‐point ordinal scales of 12 clinical, intrinsic or relational characteristics of delusions tested for their inter‐rater reliability. Results Principal Component Analysis resulted in the extraction of five factors, jointly accounting for 69.7% of the total variance. The five factors were interpreted as representing the dimensions of delusional strength, acute upsetting, delusional organization, incomprehensibility and incitation to actions. Most of the factors were differentially associated with patients' demographic, anamnestic and clinical variables. Conclusion Our results overlap in part with those of another similar study in delusional depressives of all age‐ranges, differing, however, in respects possibly attributable to peculiarities of elderly depressives. Overall, the findings of the present study contribute to the further elucidation of major clinical dimensions of delusions in PMD in the elderly and the testing of their external validity. Copyright © 2008 John Wiley & Sons, Ltd.